直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Spotlight on Upcoming Oral Arguments – April 2022

March 31, 2022

Authored and Edited by Jordan M. Gringauz; Gracie K. Mills; Esther H. Lim; Elizabeth D. Ferrill

The following arguments will be available to the public live.  Access information will be available by 9 AM ET each day of argument at: https://cafc.uscourts.gov/home/oral-argument/listen-to-oral-arguments/.

Monday, April 4, 2022

Mitek Systems, Inc. v. United Services Automobile Ass’n, No. 21-1989

United Services Automobile Association (“USAA”) holds patents relating to a mobile check depositing application. Mitek licenses its own mobile check depositing application, called MiSnapTM, to customers that include banks and financial institutions. In November 2019, Mitek sued USAA in the Northern District of California, seeking a declaratory judgment that Mitek does not infringe USAA’s patents. The case was transferred to the Eastern District of Texas, where the court dismissed the complaint on the basis that Mitek lacks standing to bring this declaratory judgment action.

On appeal, Mitek argues it has standing to bring the declaratory judgment action. Under the 5thCircuit case Choice Inc. of Texas v. Greenstein, it argues, the district court must accept as true the allegations in Mitek’s complaint. According to Mitek, accepting these allegations as true, Mitek’s complaint established standing for its declaratory judgment action. In particular, Mitek asserts that its complaint alleged facts sufficient to establish a supplier’s standing for declaratory judgment under the standard set forth in Arris Grp., Inc. v. British Telecommunications, PLC.

USAA responds that Mitek relies on the incorrect legal standard. Under Dow Jones & Co. v. Ablasie Ltd, USAA argues that Mitek bears the burden of proving the existence of a substantial controversy between the parties, and that the district court is not required to accept the allegations in Mitek’s complaint as true. Rather, USAA asserts the 5thCircuit held in Montez v Department of Navy that “where subject matter jurisdiction is being challenged, the trial court is free to weigh the evidence and resolve factual disputes in order to satisfy itself that it has the power to hear the case.” It argues that where the defendant challenges the facts alleged in the complaint, as USAA did here, the burden shifts to the plaintiff to prove the existence of subject matter jurisdiction by a preponderance of the evidence by submitting facts through some evidentiary method, citing Superior MRI Services v. Alliance Healthcare Services. According to USAA, Mitek cannot rely on the presumptive truthfulness of its allegations on appeal. Rather, it argues that Mitek must demonstrate clear error in the district court’s finding that no standing exists, citing In re Recycling, L.L.C.

Tags

Final Written Decision, United States Court of Appeals for the Federal Circuit (CAFC), Spotlight on Upcoming Oral Arguments, Patent Trial and Appeal Board (PTAB)

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Industries

AI, Electronics, and Information Technology

Electrical and Computer Technology

Life Sciences

Pharmaceutical

Related Offices

Washington, DC

Contacts

Jordan M. Gringauz
Associate
Washington, DC
+1 202 408 4143
Email
Esther H. Lim
Partner and Chief Community Officer
Washington, DC
+1 202 408 4121
Email
Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2022 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Articles

COPPA’s Amended Rule Is Now in Full Effect: What Operators Need to Know

May 15, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP